MAP
TSVT

Madison Avenue Partners’s 2seventy bio TSVT Stock Holding History

Madison Avenue Partners’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-579,895
Closed -$2.86M – 30
2025
Q1 		$2.86M Hold
579,895
– – 0.24% 17
2024
Q4 		$1.7M Sell
579,895
-1,983,327
-77% -$8.14M 0.18% 14
2024
Q3 		$12.1M Hold
2,563,222
– – 1.12% 14
2024
Q2 		$9.87M Buy
2,563,222
+130,000
+5% +$586K 1.25% 13
2024
Q1 		$13M Buy
2,433,222
+678,434
+39% +$3.19M 2.1% 10
2023
Q4 		$7.49M Buy
1,754,788
+260,663
+17% +$801K 1.06% 13
2023
Q3 		$5.86M Buy
+1,494,125
New +$9.8M 0.83% 12
2023
Q1 		– Sell
-1,199,832
Closed -$11.2M – 24
2022
Q4 		$11.2M Hold
1,199,832
– – 1.99% 14
2022
Q3 		$17.5M Sell
1,199,832
-311,468
-21% -$4.62M 3.75% 8
2022
Q2 		$19.9M Buy
1,511,300
+614,328
+68% +$8.37M 4.08% 10
2022
Q1 		$15.3M Buy
+896,972
New +$15.2M 2.86% 11

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Madison Avenue Partners's TSVT Position: Q2 2025 in Review

Madison Avenue Partners sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 579,895 shares — an estimated $2.86M sold.

Madison Avenue Partners first reported a position in TSVT in Q1 2022 and held it in 11 quarters. The position peaked at $19.9M in Q2 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Madison Avenue Partners reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Madison Avenue Partners sold 579,895 2seventy bio shares in Q2 2025, an estimated $2.86M.
  • Madison Avenue Partners first reported a position in 2seventy bio in Q1 2022 and held it in 11 quarters.
  • Madison Avenue Partners's 2seventy bio position peaked at $19.9M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Madison Avenue Partners's 13F filing for Q2 2025, filed 14 Aug 2025.